Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04202848
What this trial is testing

The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients

Who this might be right for
Lung CancerBreast CancerGastrointestinal Cancer+1 more
The First Affiliated Hospital of Dalian Medical University 500
Early research (Phase 1)Not Yet RecruitingNCT05698238
What this trial is testing

Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell Carcinoma MetastaticTNBC - Triple-Negative Breast CancerHead and Neck Cancer+2 more
Mabpro, a.s. 50
Not applicableStudy completedNCT07095348
What this trial is testing

Relationship Between Serum Xanthine Oxidase Levels and Seborrheic Keratosis

Who this might be right for
Seborrheic Keratosis (SK)Oxidative StressSkin Aging
Sri Nauli Dewi Lubis 80
Not applicableUnknownNCT06227416
What this trial is testing

Skin Tumor Biomarkers by Mass Spectrometry Imaging

Who this might be right for
Skin CancerSquamous Cell CarcinomaBasal Cell Carcinoma+1 more
Bispebjerg Hospital 300
Not applicableActive Not RecruitingNCT00582647
What this trial is testing

Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract

Who this might be right for
Esophageal CancerBile Duct NeoplasmsGastric Cancer+4 more
Memorial Sloan Kettering Cancer Center 6,000
Testing effectiveness (Phase 2)Ended earlyNCT03430947
What this trial is testing

Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases

Who this might be right for
Malignant Melanoma Stage IVBRAF V600 MutationBrain Metastases
Technische Universität Dresden 20
Not applicableStudy completedNCT03606616
What this trial is testing

Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients

Who this might be right for
Breast CancerSentinel Lymph NodeLocal Recurrence of Malignant Tumor of Breast
Peking University People's Hospital 142
Not applicableActive Not RecruitingNCT04056247
What this trial is testing

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV Malignant MelanomaStage IV Small Cell Lung Cancer+2 more
OncoHost Ltd. 10,000
Testing effectiveness (Phase 2)WithdrawnNCT03326258
What this trial is testing

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT03630354
What this trial is testing

EXERCISING TOGETHER for Couples Coping With Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+10 more
OHSU Knight Cancer Institute 496
Not applicableLooking for participantsNCT04669873
What this trial is testing

Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving Surgery

Who this might be right for
Malignant Neoplasm of Breast
Instituto Brasileiro de Controle do Cancer 36
Testing effectiveness (Phase 2)Study completedNCT01435369
What this trial is testing

Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma

Who this might be right for
MelanomaMalignant Melanoma
Medivation, Inc. 103
Early research (Phase 1)Study completedNCT01024231
What this trial is testing

Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

Who this might be right for
Malignant Melanoma
Bristol-Myers Squibb 127
Large-scale testing (Phase 3)Looking for participantsNCT05770102
What this trial is testing

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

Who this might be right for
MalignancyMalignant NeoplasmLymphoproliferative Disorders+7 more
Cancer Research UK 30
Not applicableUnknownNCT05072327
What this trial is testing

Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors.

Who this might be right for
Eyelid Tumor
Sun Yat-sen University 120
Not applicableWithdrawnNCT04176900
What this trial is testing

3D Printed Rigid Bolus Versus Silicone Bolus for Treatment of Tumors Involving the Skin: A Comparative Study

Who this might be right for
Skin Neoplasm MalignantSkin Cancer
Nova Scotia Cancer Centre
Not applicableUnknownNCT00450593
What this trial is testing

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

Who this might be right for
Hereditary Multiple MelanomaMelanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 5,000
Testing effectiveness (Phase 2)Study completedNCT00855452
What this trial is testing

Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors

Who this might be right for
Metastatic Breast CancerMalignant MelanomaRenal Cell Cancer+1 more
Hadassah Medical Organization 20
Testing effectiveness (Phase 2)Study completedNCT01395121
What this trial is testing

A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread

Who this might be right for
Mucosal Lentiginous MelanomaAcral Lentiginous Malignant Melanoma
Institute of Cancer Research, United Kingdom 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06976021
What this trial is testing

Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy

Who this might be right for
Triple Negative Breast CancerUterine Cervical CancerUterine Corpus Cancer+2 more
Maria Sklodowska-Curie National Research Institute of Oncology 60
Next Page